In The Gambia, people carry Plasmodium falciparum — the malaria parasite — asymptomatically through the dry season. The parasite is present in the bloodstream, infecting red blood cells, but doesn't cause disease. During the wet season, the same people develop clinical malaria. The standard explanation focused on mosquito transmission: wet season brings mosquitoes, mosquitoes bring new infections, new infections overwhelm the immune system. But many people already harbor the parasite year-round. The question is why the existing infection becomes symptomatic when the rains come.
A study found that plasma taurine — an amino acid that fluctuates with seasonal diet — rises during the dry season and directly inhibits infected red blood cells from clinging to blood vessel walls. The parasitized cells normally adhere to endothelial receptors (CD36, EPCR) to avoid being filtered out by the spleen. Taurine blocks this adhesion, forcing the infected cells through the splenic filtration system where they're destroyed. The body doesn't kill the parasite. It changes the parasite's relationship to the vasculature.
The mechanism inverts the standard drug model. Instead of targeting the pathogen — killing it, blocking its replication, inhibiting its enzymes — the body alters the landscape the pathogen operates in. The parasite is still alive, still infecting red blood cells. But infected cells can't anchor themselves, so they get cleared by an organ that was already there doing its job. The immune system doesn't fight harder; it lets existing infrastructure handle the problem by removing the pathogen's evasion strategy.
The seasonal variation means this is a tunable truce, not a permanent solution. When taurine drops, the infected cells regain their adhesion, the parasite evades splenic clearance, and symptoms develop. The body isn't choosing between “fight the infection” and “tolerate the infection.” It's modulating the chemical environment on a seasonal schedule, shifting the balance between clearance and evasion without eliminating either capacity. The metabolome as a control surface — adjusting not the immune response but the conditions under which the existing immune response is sufficient.